Associate Director, Research and Development and Associate Director, Product Strategy & Management; at Ultivue Inc.
BIOGRAPHY
SEP 12, 2023 9:00 AM PDT
Understanding immune activation and evasion in the tumor microenvironment: Why lymphocyte relationships matter
Speaker
Event Date & Time
Date: September 12, 2023
Time: 9:00 AM (PDT), 12:00 PM (EDT), 6:00 PM (CEST)
Abstract
In recent years, significant progress has been made in tissue-based technology, opening up unparalleled opportunities for identifying disease process biomarkers and gaining invaluable insights. Among these advancements, the utilization of tissue phenotyping and multiplex immunofluorescence (mIF) assays has emerged as a transformative approach. Notably, these assays offer a distinct advantage by preserving the architectural characteristics of the tumor microenvironment (TMA) while providing a deeper understanding of the spatial interactions between tumor cells and lymphocytes. As a result, researchers can gain comprehensive and intricate knowledge of the dynamic changes occurring within the TMA. Such advancements hold great promise for enhancing our understanding of diseases and may lead to significant breakthroughs in personalized medicine.
Learning Objectives
-
Explain the unique advantage of using mIF assays in preserving the architectural features of the tumor microenvironment (TMA) and revealing spatial interactions between tumor cells and lymphocytes.
-
Demonstrate how advanced image analysis software can be applied to discover cell types, populations and morphological and spatial context.
-
Discuss how whole slide mIF based immune profiling through InSituPlex assays can provide insight into the tumor microenvironment of specific cancer types.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...